Crossmark

Identification of EGFR inhibitors as potential agents for cancer therapy: pharmacophore-based modeling, molecular docking, and molecular dynamics investigations

Crossref DOI link: https://doi.org/10.1007/s00894-023-05531-6

Published Online: 2023-04-04

Published Print: 2023-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ashiru, Mojeed Ayoola

Ogunyemi, Sherif Olabisi

Temionu, Oluwakemi Rita

Ajibare, Abosede Christina

Cicero-Mfon, Nsikak Cicerella

Ihekuna, Ogechi Augustina

Jagun, Monsurat Olatoun

Abdulmumin, Latifatu

Adisa, Quadri Kolawole

Asibor, Yemisi Elizabeth

Okorie, Chika Joseph

Lawal, Mariam Omowumi

Babalola, Musa Oladayo

Abdulrasaq, Ibrahim Tope

Salau, Latifat Bukola

Olatunji, Idayat Omotolani

Bankole, Memunat Alake

Daud, Abibat Bisola

Adeyemi, Ayodeji Oluwadamilare
License Information

Text and Data Mining valid from 2023-04-04

Version of Record valid from 2023-04-04
More Information

Article History

Received: 22 January 2023

Accepted: 24 March 2023

First Online: 4 April 2023

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below